Navigation Links
Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010
Date:9/25/2010

and feeling hot. Most adverse reactions began soon after dosing, and generally resolved within approximately 15 minutes, except for headache, which resolved in most patients within 30 minutes.

In postmarketing experience, abdominal pain in association with nausea, vomiting, or myalgias, and diarrhea, fecal incontinence, musculoskeletal pain, and tremor have occurred.

Complete prescribing information for Lexiscan is available at www.astellas.us/docs/lexiscan.pdf.  For more information on Lexiscan, please visit www.lexiscan.com.

About Astellas

The Astellas culture and brand is committed to building community, helping others, encouraging

integrity and inspiring people to make a difference, today, tomorrow and every day. Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the United States, Astellas markets products in the areas of Anti-Infectives, Cardiology, Dermatology, Neuroscience, Transplant, and Urology. For more information about Astellas Pharma US, Inc., please visit our website at www.astellas.us or follow us on Twitter at www.Twitter.com/AstellasUS.

References

  1. Prenner BM, McNutt BE. A Study of the Safety and Tolerance of Regadenoson in Subjects with Asthma or Chronic Obstructive Pulmonary Disease. Presented at: 15th Annual Scientific Sessions of the American Society of Nuclear Cardiology; September 2010; Philadelph
    '/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
2. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
3. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
4. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
7. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
8. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
9. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
10. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
11. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... India , July 4, 2015 ... continue cible les épidémies que sont l,hypertension, le ... et du Sud-Est, par l,intermédiaire de plateformes éducatives ... maladies.      (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ... en charge le diabète en ligne , ...
(Date:7/3/2015)... MUMBAI , July 3, 2015 /PRNewswire/ ... gab heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine ... Russland erworben zu haben. Mit dieser Übernahme ... der mit einem Umsatz von 765 Mrd. ... größten Pharmamärkten der Welt gehörte (IMS Health). ...
(Date:7/2/2015)... CHAPEL HILL, N.C. , July 2, 2015 ... their own employees to capture critical product and ... there are many benefits to employee-based studies, it ... to leverage their own internal employees to capture ... recent study by benchmarking firm, Best Practices, LLC, ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Leveraging Employee Insights to Produce Cutting-Edge Market Research 2
... Holdings, Inc. (OTC Bulletin Board: ... discovery, development and commercialization of novel drugs in the ... announced that the company provided testimony at the U.S. ... Human Services (HHS) Hearing on  "Defending Against Public Health ...
... ALEXANDRIA, Va., Oct. 4 The ... new division of the association dedicated to advancing ... (Logo:   http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ... is recognized as the advocate for independent community ...
Cached Medicine Technology:Advanced Life Sciences Offers Testimony at Senate Hearing on Defending Against Public Health Threats 2Advanced Life Sciences Offers Testimony at Senate Hearing on Defending Against Public Health Threats 3Advanced Life Sciences Offers Testimony at Senate Hearing on Defending Against Public Health Threats 4NCPA Announces New Division Dedicated to Long-Term Care Pharmacies, Patients 2NCPA Announces New Division Dedicated to Long-Term Care Pharmacies, Patients 3
(Date:7/4/2015)... , ... July 04, 2015 , ... ... Surgeons published the results of an annual member survey , detailing the ... States. More recently, the group broke that raw data down into charts detailing ...
(Date:7/3/2015)... Angeles, CA (PRWEB) , ... July 03, 2015 ... ... was opened for enrollment on July 2nd creating a buzz of media attention. ... has been published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... providers, has been retained to lead a national president recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/3/2015)... TX (PRWEB) , ... July 03, 2015 , ... Jennifer ... First Choice Emergency Room , the largest network of independent freestanding emergency rooms ... new facility medical director of our Sienna Plantation facility,” said Executive Medical Director of ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is ... dresses similar to those of celebrities will have the opportunity to get 10% discount ... This ensures that people do not have to use coupon codes or remember redemption ...
Breaking Medicine News(10 mins):Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2
... influence that certain birth and infancy characteristics have on mammographic ... results reveal that women born to mothers aged over 39 ... average girl prior to puberty have a higher breast density. ... cancer. Although the role that mammographic density plays ...
... common among non-demented elderly Swedes, with an overall prevalence ... a nationwide twin study by researchers at the Aging ... higher education as a major protective factor and stresses ... cognitive disorders in old age. , , In the ...
... Feb. 5 (HealthDay News) -- More than 60 percent of ... networking site, and many spend more than two hours a ... of Child and Adolescent Psychiatry. Like many activities, social ... parents need to help their children use these sites wisely, ...
... has not only shed its stigma, it has surpassed ... than meeting through friends, according to a new analysis ... The digital revolution in romance is a boon to ... partners, reports the team of psychological scientists who prepared ...
... alone, over 4,500 children in the United States were hospitalized ... their injuries, Yale School of Medicine researchers report in a ... 2012 issue of Pediatrics (published online Feb. 6). ... occurrence of child abuse, including data from Child Protective Services. ...
... Reporter , FRIDAY, Feb. 3 (HealthDay News) -- Diabetes is ... sugar disease isn,t well-controlled, new research indicates. The study, ... the medical records of 990 men and women who had ... divided into two groups: well-controlled and poorly controlled. ...
Cached Medicine News:Health News:Women born to older mothers have a higher risk of developing breast cancer 2Health News:Cognitive problems common among non-demented elderly 2Health News:Safe Social Networking Tips for Teens 2Health News:Online dating research shows cupid's arrow is turning digital 2Health News:Online dating research shows cupid's arrow is turning digital 3Health News:Children hospitalized at alarming rate due to abuse 2Health News:Diabetes Takes Toll on Women's Hearing: Study 2
For surgical treatment, repair and irrigation of the nasolacrimal system. Stainless steel probes, 23G x4 1/2in (.60mm x 11cm) Silicone tubing, length 14in (35cm), ID: .012in (.30mm) OD: .025in (.60mm...
IOL choppers for positioning intraocular lenses. Blunt tip avoids damage to intraocular lenses. For .20mm diameter holes and larger....
...
...
Medicine Products: